MarketInOut Stock Screener Log In | Sign Up
 

Biofrontera Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
Biofrontera Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11.6 mln
Float12.84 mln
Earnings Date11/18/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

2.08
Highly suspicious

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

1.26
Elevated leverage

Pre-Tax Margin

-14%
Loss-making

ROE

-209
Deeply negative

Business Description

Biofrontera is a US-based company focused on bringing specialized skin care treatments to market. Its main product, Ameluz, is used alongside a proprietary lamp system to treat actinic keratosis, a condition where sun-damaged skin develops lesions that can become cancerous if left untreated. Founded in 2015 and operating out of Woburn, Massachusetts, the company works to make these treatments available to patients across the country.

Key Fundamentals

EPS-0.43
ROE-209
RPS3.92
ROIC-10.89
ROA-28.17
Interest Cover-18.81
EBITDA, mln-5.04
EV / EBITDA-3.50
EV / EBIT-3.02
Revenue, mln46.17
EV / Revenue0.38

Quote Details

Last 0.7891
Change 0.0081 (1.04%)
Open 0.799
Volume 102,912
Turnover 81,208
Average Volume 266,972

Financial Ratios

Pre-Tax Profit Margin-14
Leverage Ratio4.04
Current Ratio1.18
Price / Book2.57
Price / Tangible Book4.50
Debt / Equity1.26
Price / Sales0.29

Financial Strength

Altman Z-Score-6.01
Piotroski F-Score 4 / 9
Beneish M-Score2.08
Short Ratio0.21
Short % of Float1.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.96% 19 / 100   
1 Month -34.24% 9 / 100   
2 Months -24.85% 19 / 100   
6 Months -26.94% 22 / 100   
1 Year -21.87% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog